International Clinical Trial: Mechanism of Neuroinflammation in Cognitive Dysfunction of Critically Ill Patients Based on OrexinA/NF-?B Pathway

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122676) titled 'Mechanism of Neuroinflammation in Cognitive Dysfunction of Critically Ill Patients Based on OrexinA/NF-?B Pathway' on April 16.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Xiaogan Central Hospital

Condition: Sepsis-Associated Encephalopathy

Intervention: General Infection Group:None Sepsis Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-20

Target Sample Size: General Infection Group:51;Sepsis Group:51;Septic Shock Group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj...